Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile Article Swipe
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1021/acsinfecdis.6b00206
In 2013, the Centers for Disease Control highlighted Clostridium difficile as an urgent threat for antibiotic-resistant infections, in part due to the emergence of highly virulent fluoroquinolone-resistant strains. Limited therapeutic options currently exist, many of which result in disease relapse. We sought to identify molecules specifically targeting C. difficile in high-throughput screens of our diversity-oriented synthesis compound collection. We identified two scaffolds with apparently novel mechanisms of action that selectively target C. difficile while having little to no activity against other intestinal anaerobes; preliminary evidence suggests that compounds from one of these scaffolds target the glutamate racemase. In vivo efficacy data suggest that both compound series may provide lead optimization candidates.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1021/acsinfecdis.6b00206
- OA Status
- green
- Cited By
- 16
- References
- 33
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2588703681
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2588703681Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1021/acsinfecdis.6b00206Digital Object Identifier
- Title
-
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficileWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-02-19Full publication date if available
- Authors
-
Jeremy R. Duvall, Leanne L. Bedard, Adel M. Naylor-Olsen, Abigail L. Manson, Joshua A. Bittker, Wenye Sun, Mark E. Fitzgerald, Zhenmin He, Maurice D. Lee, Jean‐Charles Marié, Giovanni Muncipinto, Diane M. Rush, Deming Xu, Huisheng Xu, Mingliang Zhang, Ashlee M. Earl, Michelle Palmer, Michael A. Foley, Joseph P. Vacca, Christina SchererList of authors in order
- Landing page
-
https://doi.org/10.1021/acsinfecdis.6b00206Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1021/acsinfecdis.6b00206Direct OA link when available
- Concepts
-
Clostridium difficile, C difficile, Antibiotics, Virulence, Microbiology, Identification (biology), Biology, In vivo, Computational biology, Gene, Genetics, BotanyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
16Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1, 2023: 1, 2022: 4, 2021: 2, 2019: 2Per-year citation counts (last 5 years)
- References (count)
-
33Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2588703681 |
|---|---|
| doi | https://doi.org/10.1021/acsinfecdis.6b00206 |
| ids.doi | https://doi.org/10.1021/acsinfecdis.6b00206 |
| ids.mag | 2588703681 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/28215073 |
| ids.openalex | https://openalex.org/W2588703681 |
| fwci | 1.46404709 |
| mesh[0].qualifier_ui | Q000037 |
| mesh[0].descriptor_ui | D000591 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | antagonists & inhibitors |
| mesh[0].descriptor_name | Amino Acid Isomerases |
| mesh[1].qualifier_ui | Q000235 |
| mesh[1].descriptor_ui | D000591 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | genetics |
| mesh[1].descriptor_name | Amino Acid Isomerases |
| mesh[2].qualifier_ui | Q000378 |
| mesh[2].descriptor_ui | D000591 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | metabolism |
| mesh[2].descriptor_name | Amino Acid Isomerases |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000818 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Animals |
| mesh[4].qualifier_ui | Q000138 |
| mesh[4].descriptor_ui | D000900 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | chemical synthesis |
| mesh[4].descriptor_name | Anti-Bacterial Agents |
| mesh[5].qualifier_ui | Q000494 |
| mesh[5].descriptor_ui | D000900 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | pharmacology |
| mesh[5].descriptor_name | Anti-Bacterial Agents |
| mesh[6].qualifier_ui | Q000037 |
| mesh[6].descriptor_ui | D001426 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | antagonists & inhibitors |
| mesh[6].descriptor_name | Bacterial Proteins |
| mesh[7].qualifier_ui | Q000235 |
| mesh[7].descriptor_ui | D001426 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | genetics |
| mesh[7].descriptor_name | Bacterial Proteins |
| mesh[8].qualifier_ui | Q000378 |
| mesh[8].descriptor_ui | D001426 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | metabolism |
| mesh[8].descriptor_name | Bacterial Proteins |
| mesh[9].qualifier_ui | Q000187 |
| mesh[9].descriptor_ui | D016360 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | drug effects |
| mesh[9].descriptor_name | Clostridioides difficile |
| mesh[10].qualifier_ui | Q000201 |
| mesh[10].descriptor_ui | D016360 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | enzymology |
| mesh[10].descriptor_name | Clostridioides difficile |
| mesh[11].qualifier_ui | Q000235 |
| mesh[11].descriptor_ui | D016360 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | genetics |
| mesh[11].descriptor_name | Clostridioides difficile |
| mesh[12].qualifier_ui | Q000254 |
| mesh[12].descriptor_ui | D016360 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | growth & development |
| mesh[12].descriptor_name | Clostridioides difficile |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D015195 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Drug Design |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D004761 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Enterocolitis, Pseudomembranous |
| mesh[15].qualifier_ui | Q000382 |
| mesh[15].descriptor_ui | D004761 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | microbiology |
| mesh[15].descriptor_name | Enterocolitis, Pseudomembranous |
| mesh[16].qualifier_ui | Q000401 |
| mesh[16].descriptor_ui | D004761 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | mortality |
| mesh[16].descriptor_name | Enterocolitis, Pseudomembranous |
| mesh[17].qualifier_ui | Q000473 |
| mesh[17].descriptor_ui | D004761 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | pathology |
| mesh[17].descriptor_name | Enterocolitis, Pseudomembranous |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D005260 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Female |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D015870 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Gene Expression |
| mesh[20].qualifier_ui | Q000187 |
| mesh[20].descriptor_ui | D006090 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | drug effects |
| mesh[20].descriptor_name | Gram-Negative Bacteria |
| mesh[21].qualifier_ui | Q000254 |
| mesh[21].descriptor_ui | D006090 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | growth & development |
| mesh[21].descriptor_name | Gram-Negative Bacteria |
| mesh[22].qualifier_ui | Q000187 |
| mesh[22].descriptor_ui | D006094 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | drug effects |
| mesh[22].descriptor_name | Gram-Positive Bacteria |
| mesh[23].qualifier_ui | Q000254 |
| mesh[23].descriptor_ui | D006094 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | growth & development |
| mesh[23].descriptor_name | Gram-Positive Bacteria |
| mesh[24].qualifier_ui | Q000138 |
| mesh[24].descriptor_ui | D006574 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | chemical synthesis |
| mesh[24].descriptor_name | Heterocyclic Compounds, 2-Ring |
| mesh[25].qualifier_ui | Q000494 |
| mesh[25].descriptor_ui | D006574 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | pharmacology |
| mesh[25].descriptor_name | Heterocyclic Compounds, 2-Ring |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D051379 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Mice |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008810 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Mice, Inbred C57BL |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D008826 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Microbial Sensitivity Tests |
| mesh[29].qualifier_ui | Q000138 |
| mesh[29].descriptor_ui | D010671 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | chemical synthesis |
| mesh[29].descriptor_name | Phenylurea Compounds |
| mesh[30].qualifier_ui | Q000494 |
| mesh[30].descriptor_ui | D010671 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | pharmacology |
| mesh[30].descriptor_name | Phenylurea Compounds |
| mesh[31].qualifier_ui | Q000138 |
| mesh[31].descriptor_ui | D011758 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | chemical synthesis |
| mesh[31].descriptor_name | Pyrroles |
| mesh[32].qualifier_ui | Q000494 |
| mesh[32].descriptor_ui | D011758 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | pharmacology |
| mesh[32].descriptor_name | Pyrroles |
| mesh[33].qualifier_ui | Q000138 |
| mesh[33].descriptor_ui | D011804 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | chemical synthesis |
| mesh[33].descriptor_name | Quinolines |
| mesh[34].qualifier_ui | Q000494 |
| mesh[34].descriptor_ui | D011804 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | pharmacology |
| mesh[34].descriptor_name | Quinolines |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D013045 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Species Specificity |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D013329 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Structure-Activity Relationship |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D016019 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Survival Analysis |
| mesh[38].qualifier_ui | Q000037 |
| mesh[38].descriptor_ui | D000591 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | antagonists & inhibitors |
| mesh[38].descriptor_name | Amino Acid Isomerases |
| mesh[39].qualifier_ui | Q000235 |
| mesh[39].descriptor_ui | D000591 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | genetics |
| mesh[39].descriptor_name | Amino Acid Isomerases |
| mesh[40].qualifier_ui | Q000378 |
| mesh[40].descriptor_ui | D000591 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | metabolism |
| mesh[40].descriptor_name | Amino Acid Isomerases |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D000818 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Animals |
| mesh[42].qualifier_ui | Q000138 |
| mesh[42].descriptor_ui | D000900 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | chemical synthesis |
| mesh[42].descriptor_name | Anti-Bacterial Agents |
| mesh[43].qualifier_ui | Q000494 |
| mesh[43].descriptor_ui | D000900 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | pharmacology |
| mesh[43].descriptor_name | Anti-Bacterial Agents |
| mesh[44].qualifier_ui | Q000037 |
| mesh[44].descriptor_ui | D001426 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | antagonists & inhibitors |
| mesh[44].descriptor_name | Bacterial Proteins |
| mesh[45].qualifier_ui | Q000235 |
| mesh[45].descriptor_ui | D001426 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | genetics |
| mesh[45].descriptor_name | Bacterial Proteins |
| mesh[46].qualifier_ui | Q000378 |
| mesh[46].descriptor_ui | D001426 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | metabolism |
| mesh[46].descriptor_name | Bacterial Proteins |
| mesh[47].qualifier_ui | Q000187 |
| mesh[47].descriptor_ui | D016360 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | drug effects |
| mesh[47].descriptor_name | Clostridioides difficile |
| mesh[48].qualifier_ui | Q000201 |
| mesh[48].descriptor_ui | D016360 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | enzymology |
| mesh[48].descriptor_name | Clostridioides difficile |
| mesh[49].qualifier_ui | Q000235 |
| mesh[49].descriptor_ui | D016360 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | genetics |
| mesh[49].descriptor_name | Clostridioides difficile |
| type | article |
| title | Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile |
| awards[0].id | https://openalex.org/G10969003 |
| awards[0].funder_id | https://openalex.org/F4320337355 |
| awards[0].display_name | |
| awards[0].funder_award_id | U19 AI110818 |
| awards[0].funder_display_name | National Institute of Allergy and Infectious Diseases |
| awards[1].id | https://openalex.org/G1044601524 |
| awards[1].funder_id | https://openalex.org/F4320337355 |
| awards[1].display_name | |
| awards[1].funder_award_id | HHSN272200900018C |
| awards[1].funder_display_name | National Institute of Allergy and Infectious Diseases |
| biblio.issue | 5 |
| biblio.volume | 3 |
| biblio.last_page | 359 |
| biblio.first_page | 349 |
| topics[0].id | https://openalex.org/T11288 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | Clostridium difficile and Clostridium perfringens research |
| topics[1].id | https://openalex.org/T10195 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9429000020027161 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | Antimicrobial Resistance in Staphylococcus |
| topics[2].id | https://openalex.org/T10276 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9415000081062317 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Helicobacter pylori-related gastroenterology studies |
| funders[0].id | https://openalex.org/F4320337355 |
| funders[0].ror | https://ror.org/043z4tv69 |
| funders[0].display_name | National Institute of Allergy and Infectious Diseases |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2994496256 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8870553374290466 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q27031090 |
| concepts[0].display_name | Clostridium difficile |
| concepts[1].id | https://openalex.org/C3019428505 |
| concepts[1].level | 4 |
| concepts[1].score | 0.5880692601203918 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q574905 |
| concepts[1].display_name | C difficile |
| concepts[2].id | https://openalex.org/C501593827 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5802335739135742 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12187 |
| concepts[2].display_name | Antibiotics |
| concepts[3].id | https://openalex.org/C60987743 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5668473839759827 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1460232 |
| concepts[3].display_name | Virulence |
| concepts[4].id | https://openalex.org/C89423630 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5495914816856384 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[4].display_name | Microbiology |
| concepts[5].id | https://openalex.org/C116834253 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5335607528686523 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2039217 |
| concepts[5].display_name | Identification (biology) |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.5102555751800537 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C207001950 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4840659201145172 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q141124 |
| concepts[7].display_name | In vivo |
| concepts[8].id | https://openalex.org/C70721500 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4633773863315582 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[8].display_name | Computational biology |
| concepts[9].id | https://openalex.org/C104317684 |
| concepts[9].level | 2 |
| concepts[9].score | 0.1567842662334442 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[9].display_name | Gene |
| concepts[10].id | https://openalex.org/C54355233 |
| concepts[10].level | 1 |
| concepts[10].score | 0.128973126411438 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[10].display_name | Genetics |
| concepts[11].id | https://openalex.org/C59822182 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q441 |
| concepts[11].display_name | Botany |
| keywords[0].id | https://openalex.org/keywords/clostridium-difficile |
| keywords[0].score | 0.8870553374290466 |
| keywords[0].display_name | Clostridium difficile |
| keywords[1].id | https://openalex.org/keywords/c-difficile |
| keywords[1].score | 0.5880692601203918 |
| keywords[1].display_name | C difficile |
| keywords[2].id | https://openalex.org/keywords/antibiotics |
| keywords[2].score | 0.5802335739135742 |
| keywords[2].display_name | Antibiotics |
| keywords[3].id | https://openalex.org/keywords/virulence |
| keywords[3].score | 0.5668473839759827 |
| keywords[3].display_name | Virulence |
| keywords[4].id | https://openalex.org/keywords/microbiology |
| keywords[4].score | 0.5495914816856384 |
| keywords[4].display_name | Microbiology |
| keywords[5].id | https://openalex.org/keywords/identification |
| keywords[5].score | 0.5335607528686523 |
| keywords[5].display_name | Identification (biology) |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.5102555751800537 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/in-vivo |
| keywords[7].score | 0.4840659201145172 |
| keywords[7].display_name | In vivo |
| keywords[8].id | https://openalex.org/keywords/computational-biology |
| keywords[8].score | 0.4633773863315582 |
| keywords[8].display_name | Computational biology |
| keywords[9].id | https://openalex.org/keywords/gene |
| keywords[9].score | 0.1567842662334442 |
| keywords[9].display_name | Gene |
| keywords[10].id | https://openalex.org/keywords/genetics |
| keywords[10].score | 0.128973126411438 |
| keywords[10].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1021/acsinfecdis.6b00206 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S2764646616 |
| locations[0].source.issn | 2373-8227 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2373-8227 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | ACS Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_name | American Chemical Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_lineage_names | American Chemical Society |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ACS Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1021/acsinfecdis.6b00206 |
| locations[1].id | pmid:28215073 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | ACS infectious diseases |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/28215073 |
| locations[2].id | pmh:oai:europepmc.org:4862161 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | http://europepmc.org/pmc/articles/PMC5509442 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:5509442 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | http://doi.org/10.1021/acsinfecdis.6b00206 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5081367657 |
| authorships[0].author.orcid | https://orcid.org/0009-0004-9897-7924 |
| authorships[0].author.display_name | Jeremy R. Duvall |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[0].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[0].institutions[0].id | https://openalex.org/I107606265 |
| authorships[0].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Broad Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jeremy R. Duvall |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[1].author.id | https://openalex.org/A5064023493 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Leanne L. Bedard |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210114173 |
| authorships[1].affiliations[0].raw_affiliation_string | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[1].institutions[0].id | https://openalex.org/I4210114173 |
| authorships[1].institutions[0].ror | https://ror.org/027jt8826 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I2799321762, https://openalex.org/I4210114173 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | WuXi AppTec (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Leanne Bedard |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[2].author.id | https://openalex.org/A5053685327 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Adel M. Naylor-Olsen |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210114173 |
| authorships[2].affiliations[0].raw_affiliation_string | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[2].institutions[0].id | https://openalex.org/I4210114173 |
| authorships[2].institutions[0].ror | https://ror.org/027jt8826 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I2799321762, https://openalex.org/I4210114173 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | WuXi AppTec (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Adel M. Naylor-Olsen |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[3].author.id | https://openalex.org/A5088129247 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-3800-0714 |
| authorships[3].author.display_name | Abigail L. Manson |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[3].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[3].institutions[0].id | https://openalex.org/I107606265 |
| authorships[3].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Broad Institute |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Abigail L. Manson |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[4].author.id | https://openalex.org/A5060554702 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-4166-0828 |
| authorships[4].author.display_name | Joshua A. Bittker |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[4].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[4].institutions[0].id | https://openalex.org/I107606265 |
| authorships[4].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Broad Institute |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Joshua A. Bittker |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[5].author.id | https://openalex.org/A5049327796 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Wenye Sun |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2799321762 |
| authorships[5].affiliations[0].raw_affiliation_string | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[5].institutions[0].id | https://openalex.org/I2799321762 |
| authorships[5].institutions[0].ror | https://ror.org/04eh3ca90 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I2799321762 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | WuXi AppTec (China) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Wenye Sun |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[6].author.id | https://openalex.org/A5014370378 |
| authorships[6].author.orcid | https://orcid.org/0009-0001-9449-7892 |
| authorships[6].author.display_name | Mark E. Fitzgerald |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[6].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[6].institutions[0].id | https://openalex.org/I107606265 |
| authorships[6].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[6].institutions[0].type | nonprofit |
| authorships[6].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Broad Institute |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Mark E. Fitzgerald |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[7].author.id | https://openalex.org/A5040437183 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Zhenmin He |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2799321762 |
| authorships[7].affiliations[0].raw_affiliation_string | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[7].institutions[0].id | https://openalex.org/I2799321762 |
| authorships[7].institutions[0].ror | https://ror.org/04eh3ca90 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I2799321762 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | WuXi AppTec (China) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Zhenmin He |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[8].author.id | https://openalex.org/A5075996990 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Maurice D. Lee |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[8].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[8].institutions[0].id | https://openalex.org/I107606265 |
| authorships[8].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[8].institutions[0].type | nonprofit |
| authorships[8].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Broad Institute |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Maurice D. Lee |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[9].author.id | https://openalex.org/A5059017189 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Jean‐Charles Marié |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[9].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[9].institutions[0].id | https://openalex.org/I107606265 |
| authorships[9].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[9].institutions[0].type | nonprofit |
| authorships[9].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Broad Institute |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Jean-Charles Marie |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[10].author.id | https://openalex.org/A5048565995 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Giovanni Muncipinto |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[10].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[10].institutions[0].id | https://openalex.org/I107606265 |
| authorships[10].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[10].institutions[0].type | nonprofit |
| authorships[10].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Broad Institute |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Giovanni Muncipinto |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[11].author.id | https://openalex.org/A5021657780 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Diane M. Rush |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210114173 |
| authorships[11].affiliations[0].raw_affiliation_string | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[11].institutions[0].id | https://openalex.org/I4210114173 |
| authorships[11].institutions[0].ror | https://ror.org/027jt8826 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I2799321762, https://openalex.org/I4210114173 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | WuXi AppTec (United States) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Diane Rush |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[12].author.id | https://openalex.org/A5042239893 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Deming Xu |
| authorships[12].countries | CN |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I2799321762 |
| authorships[12].affiliations[0].raw_affiliation_string | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[12].institutions[0].id | https://openalex.org/I2799321762 |
| authorships[12].institutions[0].ror | https://ror.org/04eh3ca90 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I2799321762 |
| authorships[12].institutions[0].country_code | CN |
| authorships[12].institutions[0].display_name | WuXi AppTec (China) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Deming Xu |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[13].author.id | https://openalex.org/A5042020704 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Huisheng Xu |
| authorships[13].countries | CN |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I2799321762 |
| authorships[13].affiliations[0].raw_affiliation_string | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[13].institutions[0].id | https://openalex.org/I2799321762 |
| authorships[13].institutions[0].ror | https://ror.org/04eh3ca90 |
| authorships[13].institutions[0].type | company |
| authorships[13].institutions[0].lineage | https://openalex.org/I2799321762 |
| authorships[13].institutions[0].country_code | CN |
| authorships[13].institutions[0].display_name | WuXi AppTec (China) |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Huisheng Xu |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[14].author.id | https://openalex.org/A5100349282 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-4099-1462 |
| authorships[14].author.display_name | Mingliang Zhang |
| authorships[14].countries | CN |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I2799321762 |
| authorships[14].affiliations[0].raw_affiliation_string | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[14].institutions[0].id | https://openalex.org/I2799321762 |
| authorships[14].institutions[0].ror | https://ror.org/04eh3ca90 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I2799321762 |
| authorships[14].institutions[0].country_code | CN |
| authorships[14].institutions[0].display_name | WuXi AppTec (China) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Mingliang Zhang |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | WuXi AppTec, 168 Nanhai Road, TEDA, Tianjin 300457, China |
| authorships[15].author.id | https://openalex.org/A5079515502 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-7857-9145 |
| authorships[15].author.display_name | Ashlee M. Earl |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[15].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[15].institutions[0].id | https://openalex.org/I107606265 |
| authorships[15].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[15].institutions[0].type | nonprofit |
| authorships[15].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Broad Institute |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Ashlee M. Earl |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[16].author.id | https://openalex.org/A5112197978 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Michelle Palmer |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[16].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[16].institutions[0].id | https://openalex.org/I107606265 |
| authorships[16].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[16].institutions[0].type | nonprofit |
| authorships[16].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Broad Institute |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Michelle A. Palmer |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[17].author.id | https://openalex.org/A5045349690 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-6343-8569 |
| authorships[17].author.display_name | Michael A. Foley |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[17].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[17].institutions[0].id | https://openalex.org/I107606265 |
| authorships[17].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[17].institutions[0].type | nonprofit |
| authorships[17].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Broad Institute |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Michael A. Foley |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[18].author.id | https://openalex.org/A5112471086 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Joseph P. Vacca |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210114173 |
| authorships[18].affiliations[0].raw_affiliation_string | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[18].institutions[0].id | https://openalex.org/I4210114173 |
| authorships[18].institutions[0].ror | https://ror.org/027jt8826 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I2799321762, https://openalex.org/I4210114173 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | WuXi AppTec (United States) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Joseph P. Vacca |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | WuXi AppTec Early Risk Sharing Group, 1690 Sumneytown Pike, Suite 150, Lansdale, Pennsylvania 19446, United States |
| authorships[19].author.id | https://openalex.org/A5014556539 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-1659-2827 |
| authorships[19].author.display_name | Christina Scherer |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I107606265 |
| authorships[19].affiliations[0].raw_affiliation_string | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| authorships[19].institutions[0].id | https://openalex.org/I107606265 |
| authorships[19].institutions[0].ror | https://ror.org/05a0ya142 |
| authorships[19].institutions[0].type | nonprofit |
| authorships[19].institutions[0].lineage | https://openalex.org/I107606265 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Broad Institute |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | Christina A. Scherer |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, Massachusetts 02142, United States |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.1021/acsinfecdis.6b00206 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2017-02-24T00:00:00 |
| display_name | Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11288 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | Clostridium difficile and Clostridium perfringens research |
| related_works | https://openalex.org/W2210921572, https://openalex.org/W1977646614, https://openalex.org/W3112425173, https://openalex.org/W2415271425, https://openalex.org/W2588171602, https://openalex.org/W2014182045, https://openalex.org/W2566127862, https://openalex.org/W2081927307, https://openalex.org/W98225939, https://openalex.org/W3175123528 |
| cited_by_count | 16 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 2 |
| counts_by_year[4].year | 2019 |
| counts_by_year[4].cited_by_count | 2 |
| counts_by_year[5].year | 2018 |
| counts_by_year[5].cited_by_count | 5 |
| counts_by_year[6].year | 2017 |
| counts_by_year[6].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:5509442 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | http://doi.org/10.1021/acsinfecdis.6b00206 |
| primary_location.id | doi:10.1021/acsinfecdis.6b00206 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S2764646616 |
| primary_location.source.issn | 2373-8227 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2373-8227 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | ACS Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_name | American Chemical Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_lineage_names | American Chemical Society |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ACS Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1021/acsinfecdis.6b00206 |
| publication_date | 2017-02-19 |
| publication_year | 2017 |
| referenced_works | https://openalex.org/W2071054182, https://openalex.org/W2331725203, https://openalex.org/W1968249195, https://openalex.org/W2507523231, https://openalex.org/W2113556993, https://openalex.org/W1977591727, https://openalex.org/W2118973303, https://openalex.org/W2092488476, https://openalex.org/W1964141703, https://openalex.org/W1973367715, https://openalex.org/W2074274985, https://openalex.org/W2169023801, https://openalex.org/W2512582262, https://openalex.org/W2061733622, https://openalex.org/W1973650764, https://openalex.org/W2040351631, https://openalex.org/W2062477417, https://openalex.org/W1779785889, https://openalex.org/W1995906059, https://openalex.org/W1998450377, https://openalex.org/W2475640653, https://openalex.org/W2100618300, https://openalex.org/W2043814498, https://openalex.org/W2012016911, https://openalex.org/W2115875921, https://openalex.org/W2103441770, https://openalex.org/W1982855075, https://openalex.org/W2129153475, https://openalex.org/W2102377211, https://openalex.org/W2065373825, https://openalex.org/W2090448480, https://openalex.org/W4298337424, https://openalex.org/W2033008564 |
| referenced_works_count | 33 |
| abstract_inverted_index.C. | 47, 71 |
| abstract_inverted_index.In | 0, 97 |
| abstract_inverted_index.We | 40, 58 |
| abstract_inverted_index.an | 11 |
| abstract_inverted_index.as | 10 |
| abstract_inverted_index.in | 17, 37, 49 |
| abstract_inverted_index.no | 77 |
| abstract_inverted_index.of | 23, 34, 52, 66, 90 |
| abstract_inverted_index.to | 20, 42, 76 |
| abstract_inverted_index.due | 19 |
| abstract_inverted_index.for | 4, 14 |
| abstract_inverted_index.may | 106 |
| abstract_inverted_index.one | 89 |
| abstract_inverted_index.our | 53 |
| abstract_inverted_index.the | 2, 21, 94 |
| abstract_inverted_index.two | 60 |
| abstract_inverted_index.both | 103 |
| abstract_inverted_index.data | 100 |
| abstract_inverted_index.from | 88 |
| abstract_inverted_index.lead | 108 |
| abstract_inverted_index.many | 33 |
| abstract_inverted_index.part | 18 |
| abstract_inverted_index.that | 68, 86, 102 |
| abstract_inverted_index.vivo | 98 |
| abstract_inverted_index.with | 62 |
| abstract_inverted_index.2013, | 1 |
| abstract_inverted_index.novel | 64 |
| abstract_inverted_index.other | 80 |
| abstract_inverted_index.these | 91 |
| abstract_inverted_index.which | 35 |
| abstract_inverted_index.while | 73 |
| abstract_inverted_index.action | 67 |
| abstract_inverted_index.exist, | 32 |
| abstract_inverted_index.having | 74 |
| abstract_inverted_index.highly | 24 |
| abstract_inverted_index.little | 75 |
| abstract_inverted_index.result | 36 |
| abstract_inverted_index.series | 105 |
| abstract_inverted_index.sought | 41 |
| abstract_inverted_index.target | 70, 93 |
| abstract_inverted_index.threat | 13 |
| abstract_inverted_index.urgent | 12 |
| abstract_inverted_index.Centers | 3 |
| abstract_inverted_index.Control | 6 |
| abstract_inverted_index.Disease | 5 |
| abstract_inverted_index.Limited | 28 |
| abstract_inverted_index.against | 79 |
| abstract_inverted_index.disease | 38 |
| abstract_inverted_index.options | 30 |
| abstract_inverted_index.provide | 107 |
| abstract_inverted_index.screens | 51 |
| abstract_inverted_index.suggest | 101 |
| abstract_inverted_index.activity | 78 |
| abstract_inverted_index.compound | 56, 104 |
| abstract_inverted_index.efficacy | 99 |
| abstract_inverted_index.evidence | 84 |
| abstract_inverted_index.identify | 43 |
| abstract_inverted_index.relapse. | 39 |
| abstract_inverted_index.strains. | 27 |
| abstract_inverted_index.suggests | 85 |
| abstract_inverted_index.virulent | 25 |
| abstract_inverted_index.compounds | 87 |
| abstract_inverted_index.currently | 31 |
| abstract_inverted_index.difficile | 9, 48, 72 |
| abstract_inverted_index.emergence | 22 |
| abstract_inverted_index.glutamate | 95 |
| abstract_inverted_index.molecules | 44 |
| abstract_inverted_index.racemase. | 96 |
| abstract_inverted_index.scaffolds | 61, 92 |
| abstract_inverted_index.synthesis | 55 |
| abstract_inverted_index.targeting | 46 |
| abstract_inverted_index.anaerobes; | 82 |
| abstract_inverted_index.apparently | 63 |
| abstract_inverted_index.identified | 59 |
| abstract_inverted_index.intestinal | 81 |
| abstract_inverted_index.mechanisms | 65 |
| abstract_inverted_index.Clostridium | 8 |
| abstract_inverted_index.candidates. | 110 |
| abstract_inverted_index.collection. | 57 |
| abstract_inverted_index.highlighted | 7 |
| abstract_inverted_index.infections, | 16 |
| abstract_inverted_index.preliminary | 83 |
| abstract_inverted_index.selectively | 69 |
| abstract_inverted_index.therapeutic | 29 |
| abstract_inverted_index.optimization | 109 |
| abstract_inverted_index.specifically | 45 |
| abstract_inverted_index.high-throughput | 50 |
| abstract_inverted_index.diversity-oriented | 54 |
| abstract_inverted_index.antibiotic-resistant | 15 |
| abstract_inverted_index.fluoroquinolone-resistant | 26 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 20 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/15 |
| sustainable_development_goals[0].score | 0.4099999964237213 |
| sustainable_development_goals[0].display_name | Life in Land |
| citation_normalized_percentile.value | 0.77196895 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |